Peer Review History

Original SubmissionJanuary 14, 2022

Attachments
Attachment
Submitted filename: Response to reviewer comments.docx
Decision Letter - Francesca Crovetto, Editor

PONE-D-22-01354

Development and external validation of machine learning algorithms for postnatal gestational age estimation using clinical data and metabolomic markers

PLOS ONE

Dear Dr. Hawken,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 12 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Francesca Crovetto

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

7. Please amend the manuscript submission data (via Edit Submission) to include authors Kathryn M. Denize, Monica Lamoureux, Matthew Henderson and Joan T. Price.

8. Please upload a new copy of Figures 1-4 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/

9. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Steven Hawken and colleagues presented three machine learning-based models to estimate GA shortly after birth using clinical and metabolomics data. The models were trained and internally validated with data from Ontario - Canada and externally validated with data from Zambia and Bangladesh. I found the manuscript very interesting and it is well written. However, there are some issues that the authors should address before its publication.

- In Table 3, it would be nice to add the p-value to see whether there are statistical differences between the 3 cohorts.

- There are a couple of mistakes in Table 3: In the third column, in the birgh weight Overall row it says: 31020 grams. In addition, on the row below, there is a space missing between the mean and (SD) values.

- Lines 231-232: “Accuracy of estimated GA was generally lower in the external validation cohorts than in the Ontario internal validation results for the same models” à “Accuracy of estimated GA was generally lower in the external validation cohorts than in the Ontario internal validation COHORT for the same models”

- I cannot see Tables 4 and Table 5 properly, since they are cut.

- I am unable to see the numbers on the axis of Figure 2… Can you please make the numbers bigger? Same comment applies to Figures 3 and 4.

- Lines 325 – 334: Instead of giving the percentage of preterm births estimated by each model and for each cohort, it would be more interesting to give the number of infants correctly classified as preterm by the 3 models, and for the 3 cohorts, since, as stated by the authors, one of the main objectives of their work is the properly identification of premature infants at birth, in middle and low-income countries. When do so, please provide also, other quantitative measurements such as sensitivity, specificity, etc. for preterm detection,

- Have the infants included in this study any important disease, such as, for example congenital heart disease?

- The performance of the 3 models on correctly predicting GA in preterms is quite low (Model 3: only 28.3% of the 11 preterm infants in Zambia cohort have an absolute error o equal or below to 1 week, when using heel prick samples, for example), as seen in the results provided in tables 4 and 5. Have the authors thought on ways to improve the model performance on this subset of sample? Have the authors considered the use of other sources of data together with heel trick and clinical data? What about data imputation? Can this have a negative effect on model performance when applied to preterm subset?

- Please, carefully review your Supplementary material document, since there are some characters that are not displayed properly (i.e.: “Ontario data including only the analytes in the model with a minimum Spearman correlation coefficient of 0□5 (Model 4) and 0·3 (Model 5)”. Also, the decimal points used sometimes is wrong… It should be 0.91 instead of 0·91, for example.

- Supplementary method; “We also calculated the percentage of infants with gestational ages correctly estimated within 7 and 14 days of ultrasound-based gestational age” I thought, according to the methods described in the main manuscript, that you calculated the percentage of infant with GA correctly estimated within 1 and 7 days, since this would correspond to an error of +/-1 week. However, GA estimated within 7 and 14 days would be +/-2 weeks…

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We have uploaded a Response to Reviewer document with all comments addressed.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Francesca Crovetto, Editor

PONE-D-22-01354R1Development and external validation of machine learning algorithms for postnatal gestational age estimation using clinical data and metabolomic markersPLOS ONE

Dear Dr. Hawken,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Reviewer #1

Steven Hawken and colleagues presented three machine learning-based models to estimate GA shortly after birth using clinical and metabolomics data. The models were trained and internally validated with data from Ontario - Canada and externally validated with data from Zambia and Bangladesh. I found the manuscript very interesting and it is well written. However, there are some issues that the authors should address before its publication.

- In Table 3, it would be nice to add the p-value to see whether there are statistical differences between the 3 cohorts.

- There are a couple of mistakes in Table 3: In the third column, in the birgh weight Overall row it says: 31020 grams. In addition, on the row below, there is a space missing between the mean and (SD) values.

- Lines 231-232: “Accuracy of estimated GA was generally lower in the external validation cohorts than in the Ontario internal validation results for the same models” � “Accuracy of estimated GA was generally lower in the external validation cohorts than in the Ontario internal validation COHORT for the same models”

- I cannot see Tables 4 and Table 5 properly, since they are cut.

- I am unable to see the numbers on the axis of Figure 2… Can you please make the numbers bigger? Same comment applies to Figures 3 and 4.

- Lines 325 – 334: Instead of giving the percentage of preterm births estimated by each model and for each cohort, it would be more interesting to give the number of infants correctly classified as preterm by the 3 models, and for the 3 cohorts, since, as stated by the authors, one of the main objectives of their work is the properly identification of premature infants at birth, in middle and low-income countries. When do so, please provide also, other quantitative measurements such as sensitivity, specificity, etc. for preterm detection, 

- Have the infants included in this study any important disease, such as, for example congenital heart disease? 

- The performance of the 3 models on correctly predicting GA in preterms is quite low (Model 3: only 28.3% of the 11 preterm infants in Zambia cohort have an absolute error o equal or below to 1 week, when using heel prick samples, for example), as seen in the results provided in tables 4 and 5. Have the authors thought on ways to improve the model performance on this subset of sample? Have the authors considered the use of other sources of data together with heel trick and clinical data? What about data imputation? Can this have a negative effect on model performance when applied to preterm subset?

- Please, carefully review your Supplementary material document, since there are some characters that are not displayed properly (i.e.: “Ontario data including only the analytes in the model with a minimum Spearman correlation coefficient of 0□5 (Model 4) and 0·3 (Model 5)”. Also, the decimal points used sometimes is wrong… It should be 0.91 instead of 0·91, for example.

- Supplementary method; “We also calculated the percentage of infants with gestational ages correctly estimated within 7 and 14 days of ultrasound-based gestational age” I thought, according to the methods described in the main manuscript, that you calculated the percentage of infant with GA correctly estimated within 1 and 7 days, since this would correspond to an error of +/-1 week. However, GA estimated within 7 and 14 days would be +/-2 weeks…

Please submit your revised manuscript by Nov 25 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Francesca Crovetto

Academic Editor

PLOS ONE​

Revision 2

All responses to reviewer comments are detailed in our "Response to Reviewers" document attached to this submission.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Iman Al-Saleh, Editor

Development and external validation of machine learning algorithms for postnatal gestational age estimation using clinical data and metabolomic markers

PONE-D-22-01354R2

Dear Dr. Hawken,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Iman Al-Saleh

Academic Editor

PLOS ONE

Additional Editor Comments:

The authors satisfactorily addressed the reviewers' comments.

Formally Accepted
Acceptance Letter - Iman Al-Saleh, Editor

PONE-D-22-01354R2

Development and external validation of machine learning algorithms for postnatal gestational age estimation using clinical data and metabolomic markers

Dear Dr. Hawken:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Iman Al-Saleh

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .